Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors.
about
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance.Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase.Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
P2860
Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors.
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Pharmacological profiles of as ...... converting enzyme inhibitors.
@ast
Pharmacological profiles of as ...... converting enzyme inhibitors.
@en
Pharmacological profiles of as ...... converting enzyme inhibitors.
@nl
type
label
Pharmacological profiles of as ...... converting enzyme inhibitors.
@ast
Pharmacological profiles of as ...... converting enzyme inhibitors.
@en
Pharmacological profiles of as ...... converting enzyme inhibitors.
@nl
prefLabel
Pharmacological profiles of as ...... converting enzyme inhibitors.
@ast
Pharmacological profiles of as ...... converting enzyme inhibitors.
@en
Pharmacological profiles of as ...... converting enzyme inhibitors.
@nl
P2093
P356
P1476
Pharmacological profiles of as ...... n converting enzyme inhibitors
@en
P2093
A Matsuura
F Kobayashi
M Takahashi
N Ashikawa
N Ashizawa
P304
P356
10.1254/JJP.63.187
P577
1993-10-01T00:00:00Z